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Qfever endocarditis is caused by Coxiella burnetii,which is linked to the Rickettsia family. This is alethal but widely underestimated disease because ofinsidiousness and lack of knowledge, whereas it oc-
curs worldwide, including North America.1-3 It is a
highly resistant intracellular microorganism that is frequently in-
volved in negative blood culture endocarditis,1,4 although it is
easily detectable with a simple, low-cost, and reliable serologic
examination with immunofluorescence. Because of a close rela-
tionship with a Nationwide Referral Centre for Rickettsioses, we
have been developing surgical strategies that enabled us to more
frequently identify Q fever in patients referred for valvular inter-
ventions with or without initial suspicion for endocarditis. We
therefore observed, over a 15-year period, a consecutive series of
20 patients, representing, to our knowledge, the world’s largest
single surgical experience.5 This brief report aims to emphasize the
role of the cardiac surgeon in this difficult-to-diagnose, difficult-
to-treat endocarditis.
Clinical Summary
Between May 1987 and October 2001, a total of 20 cases of Q
fever endocarditis were diagnosed in our unit in 16 male and 4
female patients aged 36 to 79 years. Fever was reported in 13
patients and was discovered retrospectively. A peripheral embolic
event revealed the diagnosis in 2 patients. As regards predisposi-
tion of the valve for endocarditis, we observed similar previous
damage on aortic (9/20 [45%]) versus mitral (11/20 [55%]) valves
and a similar ratio between native valves (9 patients) and prosthe-
ses (11 patients). Echocardiography mostly showed paraprosthetic
leak or bioprosthetic deterioration with few signs of endocarditis,
highlighting cardiac vegetation in only 4 patients and minimal
abscess in 2 patients. Blood culture results remained negative in
every patient. The diagnosis was assessed preoperatively in only 9
patients, suspected intraoperatively in 3 patients, and discovered
postoperatively after routine bacterial analysis of valve specimens
in 4 patients. In all instances, Coxiella burnetii was identified by
means of indirect microimmunofluorescence on blood sampling,
detecting antibodies directed against phase I and phase II antigens,
with a serologic threshold of 1:800 immunoglobulin G (IgG) and
1:50 IgA. Our series showed 4 other patients having strictly normal
functioning prostheses, which were successfully treated only with
medication. We performed 8 mitral valve procedures (including 2
repairs), 7 aortic valve replacements (including 4 root replace-
ments [3 homografts]), and a double valve replacement. All pa-
tients received prolonged oral specific antibiotics (doxycycline and
hydroxychloroquine) for at least 18 months under serologic guid-
ance.1,5 We observed no operative mortality, no relapses, and 2
noncardiac late deaths (2/20 [10%]).
Comment
Coxiella burnetii endocarditis is considered rare, although it rep-
resents 3% to 5% endocarditis.1,4 In our hospital, where the Re-
ferral Center for Rickettsioses is situated, active Q fever was the
most frequent cause in the presence of negative blood culture
endocarditis, and the frequency increased with time and more
aggressive search. We first performed serologic tests between 1987
and 1993 in the presence of clinical evidence of endocarditis,
despite negative blood culture results, and then in the event of any
unexplained inflammatory syndrome associated with native valve
or prosthesis dysfunction and more recently (since 1999) for any
valve-replacement procedure. Consequently, the disease was diag-
nosed and treated in 6 patients between 1987 and 1993, 7 patients
between 1994 and 1998, and 7 patients in the last 3 years. Mac-
roscopic surgical evaluation was nonspecific and favored endocar-
ditis in only 50% of cases, retrieving little vegetation and rare
abscesses. The most common surgical observation was parapros-
thetic leak with limited inflammation of the leaflets or the anulus
or the bioprosthetic cusps. Moreover, Q fever was often assessed
through systematic search on valvular material, thus emphasizing
the role of the surgeon requesting systematic valvular sample
From the Division of Adult Cardiac Surgery, University Hospital La
Timone, Marseille, France.
Received for publication May 28, 2002; accepted for publication June 13,
2002.
Address for reprints: T. Mesana, MD, PhD, Chief, Division of Cardiac
Surgery, University of Ottawa Heart Institute, 40, Ruskin Street, Ottawa,
Ontario, Canada (E-mail: tmesana@ottawaheart.ca).
J Thorac Cardiovasc Surg 2003;125:217-8





The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 1 217
analysis, particularly with patients submitted to repeated proce-
dures for paravalvular leakage. We also observed that valve culture
results were positive, even when medication had started before the
operation. This underlines the particular resistance of the bacte-
rium because of intracellular development and the importance of
the surgical eradication, followed by long-term medical treatment
under serologic guidance. Indeed, a difficult issue arises when
active Q fever is demonstrated with normal prosthesis function,
and medication alone can be proposed. Three of our medically
treated patients were operated on during follow-up for regular
structural deterioration, although earlier replacement should be
indicated in any event as minimal paraprosthetic leak or acceler-
ated dysfunction. Finally, our low mortality rate and the absence of
relapses showed the benefit of our strategy.
Conclusion
Q fever might often go undetected in geographic low-risk zones,
such as North America, although the lack of knowledge might be
catastrophic everywhere. More aggressive search is recommended
in a variety of situations, as shown in Table 1, including systematic
analysis of surgical specimen obtained during valve procedures.
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TABLE 1. Circumstances for Q fever investigation in car-
diac surgery
1. Preoperative circumstances
A. Any negative blood culture endocarditis
B. Isolated inflammatory syndrome with native-prosthetic
valve
C. Cardiac failure with exposure to farm or pet animals
2. Intraoperative circumstances
A. Unexplained inflammatory aspect of native-prosthetic valve
B. Unexpected or repeated paravalvular leaks requiring
reoperations
C. Early-unexpected bioprosthetic cusp deterioration
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